| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4005014 | American Journal of Ophthalmology | 2007 | 7 Pages |
Abstract
Octreotide LAR had an edema-reducing effect in 70% of treated CME episodes. Successful response was related to duration of CME before start of treatment. The early recurrence of CME (63.6%) after arrest of octreotide LAR advocates a long-term treatment in recent episodes of macular edema in otherwise quiescent uveitis.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Tom Missotten, Jan A.M. van Laar, Theo L. van der Loos, Paul L.A. van Daele, Robert W.A.M. Kuijpers, G. Seerp Baarsma, P. Martin van Hagen,